Farallon Capital Management: Stock Portfolio, Performance and Latest Trades
13F portfolio value
$21.7B
89 holdings at Q2 2026
Get an email when Farallon Capital Management files a new 13F report
Free, no account needed. Unsubscribe with one click.
Farallon Capital Management's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 14.9% | $34.94 | +438% | $188.12 | Reduced −0.4% | |
Electronic Arts Inc.285512109 | 9.51% | $204.23 | — | — | Added +6.0% |
| 4.68% | $40.03 | +62.5% | $65.04 | Added +15% | |
| 4.56% | $20.91 | +569% | $139.91 | No change | |
Exelixis Inc.EXEL | 4.29% | $22.85 | +158% | $59.02 | Added +2.7% |
Liquidia Corp.LQDA | 3.90% | $17.60 | +59.2% | $28.02 | Reduced −3.4% |
Amazon.com Inc.AMZN | 3.67% | $207.70 | +22.3% | $254.06 | Reduced −38% |
| 3.63% | $75.96 | +31.8% | $100.12 | No change | |
Natera Inc.NTRA | 3.52% | $69.61 | +461% | $390.79 | Reduced −31% |
| 3.09% | $451.60 | −17.9% | $370.95 | Reduced −30% | |
| 3.08% | $484.70 | +34.5% | $651.98 | Added +19% | |
| 2.96% | $26.90 | +27.2% | $34.21 | Added +48% | |
| 2.68% | $331.14 | −16.3% | $277.12 | Reduced −45% | |
| 2.63% | $68.60 | −38.7% | $42.04 | Added +41% | |
Broadcom Inc.AVGO | 2.55% | $343.37 | +4.9% | $360.14 | Reduced −35% |
Microsoft Corp.MSFT | 2.43% | $355.62 | +47.0% | $522.61 | Reduced −53% |
| 2.25% | $9.92 | +128% | $22.57 | Added +35% | |
| 2.21% | $113.60 | −21.2% | $89.56 | Reduced −12% | |
Synopsys Inc.SNPS | 2.17% | $445.61 | +11.7% | $497.75 | Reduced −32% |
| 2.06% | $39.95 | −38.4% | $24.60 | Added +1.0% | |
Crinetics Pharmaceuticals In22663K107 | 1.97% | $44.54 | — | — | Added +7.8% |
Grail Inc.GRAL | 1.66% | $56.93 | +133% | $132.61 | Added +28% |
Wabtec Corp.WAB | 1.41% | $146.34 | +91.9% | $280.80 | Reduced −44% |
Immunovant Inc.IMVT | 1.31% | $29.25 | +3.4% | $30.26 | Added +275% |
| 1.29% | $51.54 | +195% | $152.05 | Added +50% | |
| 1.29% | $28.88 | +10.5% | $31.92 | Added +4.1% | |
AramarkARMK | 1.21% | $33.85 | +64.1% | $55.54 | Reduced −41% |
| 0.81% | $120.83 | −30.5% | $83.92 | Added +171% | |
| 0.73% | $44.28 | −13.8% | $38.18 | Added +235% | |
| 0.73% | $22.56 | +26.2% | $28.48 | Added +143% | |
| 0.71% | $40.92 | +55.6% | $63.66 | Added +7.2% | |
| 0.64% | $189.95 | −16.4% | $158.78 | Added +153% | |
| 0.61% | $233.01 | +10.1% | $256.48 | Added +176% | |
Strategy Inc.Bond594972AS0 | 0.44% | — | — | — | Added +122% |
| 0.38% | $27.37 | +2.6% | $28.09 | New | |
| 0.33% | $149.91 | −4.5% | $143.11 | New | |
| 0.28% | $108.20 | +53.0% | $165.56 | Added +3928% | |
Vnet Group Inc.Bond90138AAE3 | 0.27% | — | — | — | No change |
| 0.27% | $15.74 | −14.7% | $13.43 | Added +173% | |
Joyy Inc-AdrJOYY | 0.27% | $47.94 | +68.6% | $80.85 | Added +21% |
| 0.26% | $23.18 | −1.6% | $22.82 | Added +31% | |
| 0.21% | $39.82 | −69.6% | $12.10 | Reduced −16% | |
| 0.19% | $32.24 | −19.7% | $25.88 | Added +197% | |
| 0.15% | $115.45 | +23.3% | $142.38 | Reduced −45% | |
| 0.15% | $24.76 | +0.8% | $24.95 | New | |
Freenome Inc.FRNM | 0.14% | $11.28 | +40.2% | $15.81 | No change |
| 0.14% | $21.98 | −54.5% | $10.00 | New | |
| 0.10% | $98.39 | −5.1% | $93.34 | Added +241% | |
| 0.10% | $30.08 | +9.1% | $32.81 | New | |
Abivax Sa-AdrABVX | 0.10% | $132.47 | −32.8% | $89.05 | Added +6000% |
Vnet Group Inc.VNET | 0.09% | $8.80 | −41.3% | $5.17 | Added +220% |
Netease Inc-AdrNTES | 0.09% | $124.07 | −3.6% | $119.60 | Reduced −58% |
Biogen Inc.BIIB | 0.09% | $191.29 | +14.2% | $218.43 | New |
| 0.09% | $5.92 | −25.1% | $4.43 | New | |
| 0.09% | $12.95 | −33.9% | $8.56 | New | |
Strategy Inc.Bond594972AN1 | 0.08% | — | — | — | New |
| 0.08% | $4.02 | −19.9% | $3.22 | No change | |
| 0.07% | $22.63 | +14.5% | $25.91 | New | |
Alvotech SAALVO | 0.06% | $4.13 | +37.1% | $5.67 | Added +1332% |
| 0.05% | $17.71 | −1.6% | $17.43 | Reduced −84% | |
Inflarx NVIFRX | 0.04% | $1.88 | −18.6% | $1.53 | New |
| 0.04% | $61.94 | −18.6% | $50.43 | New | |
| 0.03% | $21.03 | +25.9% | $26.48 | New | |
| 0.03% | $80.16 | −22.2% | $62.35 | New | |
Gentex Corp.GNTX | 0.03% | $23.65 | −10.6% | $21.15 | New |
| 0.03% | $560.90 | −8.5% | $513.14 | New | |
| 0.03% | $4.62 | −22.5% | $3.58 | No change | |
| 0.02% | $70.32 | −10.3% | $63.10 | New | |
| 0.02% | $10.63 | −0.7% | $10.56 | New | |
| 0.02% | $6.80 | +31.2% | $8.92 | New | |
Strategy Inc.Bond594972AU5 | 0.01% | — | — | — | New |
| 0.01% | $36.10 | −9.4% | $32.69 | No change | |
| 0.01% | $30.52 | +28.6% | $39.25 | Reduced −89% | |
| 0.01% | $0.33 | +2761% | $9.44 | No change | |
| 0.00% | $6.41 | +369% | $30.08 | No change | |
Aleanna Inc.ANNAW | 0.00% | $0.14 | +78.6% | $0.25 | No change |
Aleanna Inc.ANNA | 0.00% | $0.9536 | +167% | $2.55 | No change |
Welltower Inc.WELL | 0.00% | $186.78 | +19.4% | $223.04 | Reduced −100% |
| 0.00% | $2.29 | — | — | No change | |
Blue Gold Ltd.BGLWW | 0.00% | $0.4682 | −92.0% | $0.0375 | Reduced −15% |
| 0.00% | $10.13 | −77.3% | $2.30 | Reduced −89% | |
Geron Corp.GERN | 0.00% | $3.63 | −66.4% | $1.22 | Reduced −67% |
Nvni Group Ltd-28NVNIW | 0.00% | $0.0355 | −71.3% | $0.0102 | No change |
| 0.00% | $6.45 | −86.9% | $0.847 | Reduced −40% | |
| 0.00% | $1.35 | −41.3% | $0.792 | Reduced −73% | |
Beyond Meat Inc.08862E109 | 0.00% | $3.49 | — | — | No change |
Farallon Capital Management's options
As of Q2 2026. Value = shares the options cover.
| Company | Type | Value of shares covered | Last quarter |
|---|---|---|---|
| Put · bet on a fall or hedge | $4.5B | New | |
| Put · bet on a fall or hedge | $83.3M | New | |
CG Oncology Inc.CGON | Call · bet on a rise | $28.4M | New |
CG Oncology Inc.156944900 | Call · bet on a rise | — | Sold out |
Invesco S&P 500 Equal Weight46137V957 | Put · bet on a fall or hedge | — | Sold out |
SS Spdr S&P 500 ETF Trust-Us78462F953 | Put · bet on a fall or hedge | — | Sold out |
Farallon Capital Management's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
| Sold out | −3,000,000 | — | |
SS Spdr S&P 500 ETF Trust-UsPut78462F953 | New | +2,300,000 | $1.5B |
Invesco S&P 500 Equal WeightPut46137V957 | New | +3,600,000 | $690.9M |
| Sold out | −3,600,000 | — | |
Exact Sciences Corp.30063P105 | Sold out | −6,405,000 | — |
| Sold out | −8,000,000 | — | |
Electronic Arts Inc.285512109 | Added +48% | +2,435,000 | $1.5B |
| Sold out | −1,053,040 | — | |
Eli Lilly & Co.PutLLY | Sold out | −375,000 | — |
| Sold out | −1,261,177 | — | |
Nasdaq Inc.NDAQ | Sold out | −2,989,213 | — |
| Added +26049% | +9,638,000 | $268M | |
Natera Inc.NTRA | Reduced −18% | −707,000 | $641.4M |
Broadcom Inc.AVGO | Added +99% | +887,100 | $550.8M |
| Added +0.4% | +31,120 | $468.8M | |
| Reduced −42% | −1,724,400 | $231.5M | |
Avidity Biosciences Inc.05370A108 | Sold out | −3,233,000 | — |
| Sold out | −3,280,678 | — | |
Microsoft Corp.MSFT | Added +5.9% | +130,700 | $868M |
Dayforce Inc.15677J108 | Sold out | −2,925,000 | — |
| Added +132% | +2,654,100 | $432.1M | |
| Reduced −82% | −2,782,500 | $26.9M | |
| Reduced −6.7% | −978,000 | $1.3B | |
Amazon.com Inc.AMZN | Reduced −6.3% | −281,500 | $878.6M |
| Sold out | −983,771 | — | |
| Added +3.3% | +204,900 | $669.2M | |
| Reduced −5.7% | −152,600 | $811M | |
Wabtec Corp.WAB | Reduced −35% | −866,600 | $402.2M |
Exelixis Inc.EXEL | Reduced −17% | −2,598,490 | $562.3M |
| Added +152% | +262,400 | $217.4M | |
| Reduced −100% | −3,376,986 | $207.6K | |
| Sold out | −2,137,100 | — | |
AramarkARMK | Reduced −34% | −3,221,615 | $248.7M |
| Reduced −16% | −706,000 | $36.2M | |
| Sold out | −382,800 | — | |
| Added +73% | +1,514,000 | $137.1M | |
| Reduced −30% | −3,964,000 | $190.3M | |
Vaxcyte Inc.PCVX | Added +25120% | +1,256,000 | $73.3M |
| New | +836,000 | $70.2M | |
| Added +7250% | +1,595,000 | $68.9M | |
| Added +18562% | +1,420,000 | $67.8M | |
| Added +39% | +245,800 | $433.3M | |
| Added +2.9% | +156,000 | $423.5M | |
TransunionTRU | Sold out | −675,000 | — |
Centessa Pharmaceuticals-Adr152309100 | Reduced −11% | −568,068 | $191M |
Abivax Sa-AdrABVX | Reduced −99% | −385,000 | $222.7K |
| Added +10% | +524,495 | $192.3M | |
Vnet Group Inc.VNET | Reduced −90% | −5,662,039 | $5.2M |
CG Oncology Inc.CGON | Added +8325% | +666,000 | $45.6M |
| New | +226,499 | $44.7M | |
Vnet Group Inc.Bond90138AAE3 | New | +45,000,000 | $44.5M |
Insmed Inc.CallINSM | Sold out | −250,000 | — |
| New | +361,000 | $43.4M | |
| Reduced −22% | −64,600 | $202.8M | |
| New | +1,736,800 | $40.6M | |
| Reduced −36% | −208,000 | $77.8M | |
Alnylam PharmaceuticalsPutALNY | Sold out | −100,000 | — |
Alphabet Inc.GOOG | Added +27% | +209,191 | $285.8M |
Immunovant Inc.IMVT | Added +12783% | +1,534,000 | $38.4M |
| Added +18% | +616,000 | $371.8M | |
| Added +0.7% | +71,585 | $241.5M | |
| New | +148,000 | $36.2M | |
| Added +14% | +222,800 | $492.9M | |
| Sold out | −1,481,001 | — | |
Strategy Inc.Bond594972AS0 | New | +39,500,000 | $32.9M |
Netease Inc-AdrNTES | New | +291,219 | $32.6M |
Grail Inc.GRAL | Added +39% | +911,000 | $168.2M |
| Sold out | −454,000 | — | |
| Sold out | −823,296 | — | |
Sunococorp LLCSUNC | Sold out | −606,277 | — |
| New | +782,000 | $28.7M | |
Terns Pharmaceuticals Inc.880881107 | Reduced −99% | −635,000 | $369K |
| Reduced −99% | −231,500 | $290.2K | |
Welltower Inc.WELL | Reduced −42% | −143,000 | $39.5M |
| New | +493,000 | $23.6M | |
Crinetics Pharmaceuticals In22663K107 | Added +20% | +1,405,000 | $302.8M |
Verastem Inc.VSTM | Sold out | −2,000,000 | — |
| New | +234,000 | $13.9M | |
| Sold out | −311,000 | — | |
| New | +916,000 | $13.7M | |
| Reduced −78% | −360,000 | $4.7M | |
CG Oncology Inc.Call156944900 | New | +200,000 | $13.5M |
| New | +292,000 | $11.8M | |
Synopsys Inc.SNPS | Added +21% | +214,100 | $481M |
| Added +21% | +80,000 | $85.3M | |
| New | +373,000 | $11.1M | |
| Sold out | −260,000 | — | |
| Sold out | −196,000 | — | |
| Reduced −93% | −101,000 | $739K | |
| Added +21% | +144,800 | $254.1M | |
| Added +785% | +314,000 | $10.7M | |
| Reduced −93% | −65,000 | $321.1K | |
| Added +41% | +128,485 | $49.4M | |
| Added +3.6% | +99,600 | $36.3M | |
| Added +4.1% | +367,000 | $695.5M | |
| Sold out | −228,340 | — | |
Formfactor Inc.FORM | New | +56,500 | $5.5M |
Mastec Inc.MTZ | New | +17,000 | $5.5M |
Entegris Inc.ENTG | New | +45,500 | $5.3M |
| New | +47,000 | $5.3M | |
| New | +36,000 | $5.2M | |
| New | +73,000 | $5.2M | |
Timken Co.TKR | New | +51,000 | $5.1M |
Flex Ltd.FLEX | New | +78,000 | $5.1M |
S&P Global Inc.SPGI | New | +12,000 | $5.1M |
Littelfuse Inc.LFUS | New | +15,000 | $5.1M |
| New | +66,000 | $5.1M | |
Aar Corp.AIR | New | +46,000 | $5M |
| New | +53,800 | $5M | |
| New | +275,000 | $5M | |
Rollins Inc.ROL | New | +93,000 | $5M |
| New | +108,000 | $4.9M | |
| New | +614,500 | $4.9M | |
Cummins Inc.CMI | New | +9,000 | $4.8M |
Fiserv Inc.FISV | New | +86,000 | $4.8M |
| New | +19,000 | $4.8M | |
| New | +349,360 | $4.7M | |
| New | +105,000 | $4.7M | |
| New | +35,000 | $4.7M | |
| New | +1,000,000 | $4.6M | |
| New | +265,000 | $4.5M | |
| New | +41,000 | $4.3M | |
| Reduced −96% | −253,000 | $126.2K | |
Novavax Inc.NVAX | Reduced −89% | −173,000 | $179.1K |
Schrodinger Inc.SDGR | Reduced −76% | −54,000 | $193.1K |
Insmed Inc.INSM | Sold out | −3,000 | — |
Ascendis Pharma A/S04351P101 | Sold out | −1,400 | — |
Erasca Inc.ERAS | New | +18,000 | $291.2K |
| New | +4,000 | $287.8K | |
Arcellx Inc.03940C100 | Sold out | −4,000 | — |
Alumis Inc.ALMS | New | +11,000 | $242.3K |
Apellis Pharmaceuticals03753U106 | New | +6,000 | $241.4K |
| Reduced −50% | −1,000 | $258.3K | |
Soleno Therapeutics Inc.834203309 | Sold out | −5,000 | — |
| Reduced −44% | −2,200 | $234K | |
Icon PLCICLR | Sold out | −1,200 | — |
| Sold out | −3,000 | — | |
| New | +1,300 | $207.3K | |
| New | +4,000 | $206.8K | |
| New | +22,000 | $197.1K | |
| New | +40,000 | $169.2K | |
| Reduced −50% | −21,787 | $68.2K |
Farallon Capital Management's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 62% |
| Technology | 12% |
| Other | 12% |
| Financials | 8.1% |
| Consumer Discretionary | 5.0% |
| Industrials | 1.5% |
| Materials | 0.3% |
| Energy | 0.0% |
| Real Estate | 0.0% |
Portfolio performance: Farallon Capital Management vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +56.8% | +9.4% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 56% of the portfolio value on average; the rest is left out of the return.
Farallon Capital Management's most traded stocks
Quarters with a buy or a sell, all reports since Q2 2013.
| Company | Quarters bought | Quarters sold |
|---|---|---|
Microsoft Corp.MSFT | 25 | 27 |
Alphabet Inc.GOOG | 19 | 24 |
| 19 | 22 | |
Wabtec Corp.WAB | 20 | 18 |
Exelixis Inc.EXEL | 21 | 16 |
TransunionTRU | 15 | 20 |
| 20 | 13 | |
| 18 | 11 | |
Grifols Sa-AdrGRFS | 14 | 14 |
| 15 | 12 | |
| 10 | 17 | |
| 15 | 11 | |
| 16 | 10 | |
| 14 | 12 | |
| 13 | 12 |